Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 22;9(5):e027509.
doi: 10.1136/bmjopen-2018-027509.

Prolonged infusion with β-lactam antibiotics for treatment of infection caused by non-susceptible bacteria: a study protocol for a systemic review and meta-analysis

Affiliations

Prolonged infusion with β-lactam antibiotics for treatment of infection caused by non-susceptible bacteria: a study protocol for a systemic review and meta-analysis

Huadong Chen et al. BMJ Open. .

Abstract

Introduction: Prolonged infusion with β-lactam antibiotics should theoretically produce a better clinical efficacy than intermittent infusion in severe infection and infection caused by non-susceptible micro-organisms. The efficacy of prolonged infusion in severe infection has been well illustrated recently, but is still confusing in non-susceptible microbial infection. The objective of this meta-analysis is to determine the clinical effects of prolonged infusion with β-lactams for patients infected by microbes non-susceptible to the given drug.

Methods and analysis: Literature searches will be performed with Medline, the Cochrane database, EMBASE database, Cumulative Index to Nursing and Allied Health Literature database, the Chinese National Knowledge Infrastructure and Wanfang database. Two reviewers will screen and select studies according to a priori defined eligibility criteria, and then the data from the included studies will be extracted. The quality will be evaluated based on a modified Jadad score and the Newcastle-Ottawa system for randomised controlled trials and observational studies, respectively. Data synthesis will be performed with Review Manager 5.3 software. Sensitivity analysis and publication bias will also be investigated.

Ethics and dissemination: No ethics approval is required. The full article will be published in a peer-reviewed journal and presented at international conferences.

Prospero registration number: CRD42018105111.

Keywords: clinical pharmacology; infection control; infectious diseases; microbiology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Cited by

References

    1. Collignon P. Antibiotic resistance: are we all doomed? Intern Med J 2015;45:1109–15. 10.1111/imj.12902 - DOI - PubMed
    1. Plantinga NL, Wittekamp BH, van Duijn PJ, et al. . Fighting antibiotic resistance in the intensive care unit using antibiotics. Future Microbiol 2015;10:391–406. 10.2217/fmb.14.146 - DOI - PubMed
    1. Abdul-Aziz MH, Lipman J, Mouton JW, et al. . Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development. Semin Respir Crit Care Med 2015;36:136–53. 10.1055/s-0034-1398490 - DOI - PubMed
    1. Kitamura Y, Yoshida K, Kusama M, et al. . A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics. Drug Metab Pharmacokinet 2014;29:455–62. 10.2133/dmpk.DMPK-14-RG-013 - DOI - PubMed
    1. Kaye KS, Pogue JM. Infections caused by resistant gram-negative bacteria: epidemiology and management. Pharmacotherapy 2015;35:949–62. 10.1002/phar.1636 - DOI - PubMed

MeSH terms